USPTO Examiner BERTRAM ERIC D - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19223670DEFIBRILLATOR DESIGNED FOR HIGH-RELIABILITY OPERATIONMay 2025November 2025Allow511YesNo
19018936DEFIBRILLATOR UTILIZING A MULTI-WINDING TRANSFORMERJanuary 2025March 2026Allow1431YesNo
19018982DEFIBRILLATOR WITH BIAS GENERATION CIRCUIT UTILIZING BRIDGE POWER RECTIFICATIONJanuary 2025July 2025Allow610NoNo
19018819DEFIBRILLATOR WITH BIAS GENERATION CIRCUIT UTILIZING SYNCHRONOUS POWER RECTIFICATIONJanuary 2025July 2025Allow611YesNo
18980733DISTRIBUTED DEFIBRILLATOR SYSTEM TO ENABLE RAPID RESPONSE FOR CARDIAC OR PULMONARY ARRESTDecember 2024June 2025Allow610NoNo
18908315DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH MAGNET REMOVALOctober 2024January 2026Allow1531YesNo
18908144DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH CASE OPENINGOctober 2024August 2025Allow1021YesNo
18806588CIRCUIT FOR DEFIBRILLATION WAVEFORM GENERATIONAugust 2024February 2025Allow611NoNo
18730169SYSTEM, METHOD AND APPRATUS FOR OBJECTIVELY SCREENING DEPRESSIONJuly 2024March 2026Allow2000NoNo
18750336SYSTEMS AND METHODS FOR TRACKING CARDIAC VALUESJune 2024August 2025Allow1430YesNo
18749377DEFIBRILLATOR CASEJune 2024September 2025Allow1530NoNo
18641214DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH CASE OPENINGApril 2024November 2024Allow711YesNo
18641220DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH PAD REMOVALApril 2024November 2024Allow711YesNo
18629491DENTAL INSTRUMENT CAMERA APPARATUSApril 2024October 2025Abandon1820NoNo
18597296SYSTEM, METHOD, AND APPARATUS FOR VISUALIZING CARDIAC TIMING INFORMATION USING ANIMATIONSMarch 2024August 2025Allow1810NoNo
18593703FORAMINA-FILLING IMPLANTABLE MEDICAL LEADMarch 2024March 2026Allow2411YesNo
18440722BIOSTIMULATOR HAVING RESILIENT SCAFFOLDFebruary 2024February 2026Allow2431YesNo
18440876DEVICES, SYSTEMS, AND METHODS FOR CARDIAC RESYNCHRONIZATION THERAPYFebruary 2024September 2025Allow1911NoNo
18433340ELECTRODE AND PERCUTANEOUS LEAD AND METHOD OF USEFebruary 2024July 2025Allow1820NoNo
18416482Automated External Defibrillator Systems with Operation Adjustment Features According to Temperature and Methods of UseJanuary 2024October 2024Allow910NoNo
18401199DE-ENERGIZABLE DEFIBRILLATION ASSEMBLYDecember 2023August 2024Allow821YesNo
18531570SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN, INCLUDING CEPHALIC AND/OR TOTAL BODY PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODSDecember 2023August 2025Allow2010NoNo
18522788SURGICAL GENERATOR FOR ULTRASONIC AND ELECTROSURGICAL DEVICESNovember 2023May 2025Allow1730NoNo
18516820POSITIVE SYSTEM ALERTSNovember 2023October 2025Allow2311NoNo
18511832Systems, Devices, Components and Methods for Detecting the Locations of Sources of Cardiac Rhythm Disorders in a Patient's HeartNovember 2023February 2026Allow2711NoNo
18387221IMPLANTABLE STIMULATING ASSEMBLY WITH LIMITED COMPONENTSNovember 2023October 2025Allow2320YesYes
18501026MULTIELECTRODE MEDICAL LEAD WITH FIXATIONNovember 2023December 2024Allow1321YesNo
18499721EXTRAVASCULAR IMPLANTABLE ELECTRICAL LEAD HAVING UNDULATING CONFIGURATIONNovember 2023May 2025Allow1820YesNo
18557809LEADLESS LEFT-BUNDLE-BRANCH PACEMAKEROctober 2023March 2025Allow1610NoNo
18486992DEFIBRILLATOR CASEOctober 2023September 2024Allow1230YesNo
18379182Multi-label Electrocardiogram (ECG) Signal Classification Method Based on Improved Attention MechanismOctober 2023January 2025Allow1600NoNo
18378379Respiration Monitoring Sensor for a Laryngeal PacemakerOctober 2023September 2025Allow2300NoNo
18483514EXTERNAL DEFIBRILLATOROctober 2023August 2024Allow1010NoNo
18474135TREATING DEGENERATIVE DEMENTIA WITH LOW INTENSITY FOCUSED ULTRASOUND PULSATION (LIFUP) DEVICESeptember 2023April 2025Allow1821NoNo
18371044ACTIVE IMPLANTED DEVICE (AIMD) WITH IN SITU OPTIMIZATION OF POWER CONSUMPTIONSeptember 2023November 2023Allow210NoNo
18550968HEALTH MONITORING SYSTEM AND METHODSeptember 2023February 2026Abandon2910NoNo
18367566BALLOON-TYPE RETINAL STIMULATION DEVICE AND METHOD FOR MANUFACTURING SAMESeptember 2023March 2026Allow3011NoNo
18451211DEVICES AND METHODS FOR IMPROVED FOLLOWABILITY IN LASER-BASED OCULAR PROCEDURESAugust 2023February 2026Allow3021YesNo
18229134MANAGING ALERTS IN A WCD SYSTEMAugust 2023May 2024Allow910NoNo
18226075DETECTION OF IMPLANTABLE DEVICE ROTATION USING RESPIRATORY SIGNALSJuly 2023July 2025Allow2400NoNo
18343994METHOD OF USING A MEDICAL DEVICEJune 2023October 2023Allow410YesNo
18209852Wearable Auricular Neurostimulator and Methods of UseJune 2023February 2024Allow811NoNo
18330820ACCESSORY-BASED STORAGE FOR USE WITH A MEDICAL DEVICEJune 2023May 2024Allow1110NoNo
18331109SIGNAL DELIVERY DEVICES TO TREAT SLEEP APNEA, AND ASSOCIATED METHODS AND SYSTEMSJune 2023January 2024Allow811YesNo
18265446INTRAESOPHAGEAL ELECTROSTIMULATORJune 2023January 2024Allow710YesNo
18202500ARM ASSEMBLY FOR SURGICAL ROBOTMay 2023February 2026Allow3320NoNo
18316746Photoplethysmography-Based Pulse Wave Analysis Using a Wearable DeviceMay 2023April 2024Allow1110YesNo
18251337NONINVASIVE HEART FAILURE DETECTIONMay 2023October 2025Allow3010NoNo
18141024REINFORCED ELECTRODE LEADS AND METHODS FOR MANUFACTURING THE SAMEApril 2023January 2025Allow2121YesNo
18309073METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATIONApril 2023August 2024Allow1511NoNo
18139331HEADSETS FOR POSITIONING ELECTRONIC DEVICESApril 2023December 2024Allow2031NoNo
18032926Pocket-Sized Automated External DefibrillatorApril 2023November 2023Allow700NoNo
18302914LEADLESS CARDIAC PACEMAKER DEVICE CONFIGURED TO PROVIDE HIS BUNDLE PACINGApril 2023December 2024Allow2030NoNo
18127738INTRAVASCULAR BLOOD PUMPMarch 2023April 2024Allow1210NoNo
18127291Apparatus For Working On Eye Tissue By Means Of A Pulsed Laser BeamMarch 2023March 2024Allow1110NoNo
18125922KINEMATIC STRUCTURES AND STERILE DRAPES FOR ROBOTIC MICROSURGICAL PROCEDURESMarch 2023September 2025Allow3010NoNo
18188120TREATMENT FOR LOSS OF CONTROL DISORDERSMarch 2023September 2024Allow1811NoNo
18027446MEDICAL INSTRUMENT SYSTEM COMPRISING A SURGICAL TOOLMarch 2023September 2025Allow3010NoNo
18122304APPARATUS AND METHOD FOR TREATING MULTIPLE TUMORS IN PATIENTS WITH METASTATIC DISEASE BY ELECTRIC FIELDSMarch 2023April 2024Allow1310NoNo
18026443SYSTEM AND METHOD FOR RESTORING COLOR PERCEPTION TO THE BLINDMarch 2023October 2025Allow3120NoNo
18180569EXTERNAL SYSTEM FOR IMPLANTED MEDICAL DEVICESMarch 2023October 2024Allow2030YesNo
18015357IMPLANTABLE IN-LINE HIGH DENSITY CONNECTORJanuary 2023September 2025Allow3220NoNo
18149763PERCUTANEOUS NERVE EVALUATION FOR SACRAL NEUROMODULATIONJanuary 2023December 2023Allow1210NoNo
18146612SYSTEM, METHOD, AND APPARATUS FOR VISUALIZING CARDIAC TIMING INFORMATION USING ANIMATIONSDecember 2022December 2023Allow1210NoNo
18065376FORAMINAL LIGAMENT ANCHOR FOR APPLICATION IN DRG THERAPYDecember 2022November 2024Allow2320NoNo
18076903HEARING PROSTHESISDecember 2022May 2024Allow1720NoNo
18075168IMPLANTABLE LEAD WITH EXTENSIBLE ELECTRODE AND REPOSITIONING FEATURESDecember 2022May 2024Allow1721NoNo
18000624AUTOMATED EXTERNAL DEFIBRILLATORDecember 2022January 2026Allow3720YesNo
18073659WEARABLE MEDICAL SYSTEM (WMS) IMPLEMENTING WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) CAPTURING, RECORDING AND REPORTING AMBIENT SOUNDSDecember 2022November 2025Allow3511NoNo
18008078AUTOMATED EXTERNAL DEFIBRILLATORDecember 2022July 2025Allow3110NoNo
18000021SENSORY UNIT FOR DENTAL IMPLANTSNovember 2022January 2026Abandon3820NoNo
17928139ELECTRODE PLATE AND WEARABLE DEFIBRILLATION DEVICENovember 2022March 2025Allow2700NoNo
18058024Cell Phone DefibrillatorNovember 2022January 2026Abandon3721NoNo
17991393BIOSTIMULATOR TRANSPORT SYSTEM HAVING WELDLESS BEARING RETAINERNovember 2022August 2024Allow2121YesNo
17982740IMPLANTABLE MEDICAL DEVICE WITH A FLEXIBLE HELICAL ANCHORING SCREWNovember 2022April 2024Allow1810NoNo
17982674IMPLANTABLE MEDICAL DEVICE WITH A NON-TRAUMATIC HELICAL ANCHORING SCREWNovember 2022February 2024Allow1500NoNo
17922876HYBRID MULTI-PHASIC STIMULATIONNovember 2022December 2025Allow3821YesNo
17975468METHOD AND APPARATUS FOR CLINICAL EFFECTS-BASED TARGETING OF NEUROSTIMULATIONOctober 2022January 2024Allow1510NoNo
17973739ELECTROCARDIOGRAM WAVE SEGMENTATION USING MACHINE LEARNINGOctober 2022January 2026Allow3821NoNo
18046042STIMULATION APPARATUSOctober 2022April 2025Allow3130YesNo
17962746SYSTEMS AND METHODS FOR PRESENTING ARRHYTHMIA EPISODESOctober 2022April 2025Allow3001NoNo
17917925Intracardiac energy harvesting device and implantable electronic medical deviceOctober 2022March 2024Allow1710NoNo
17956165DYNAMIC STIMULUS RESOLUTION ADAPTIONSeptember 2022May 2024Allow1910NoNo
17913612PACING DEVICE AND METHOD OF OPERATION THEREOFSeptember 2022January 2026Allow4030NoNo
17942710COCHLEAR IMPLANT STIMULATION CALIBRATIONSeptember 2022July 2025Allow3411YesNo
17930566GARMENTS FOR WEARABLE CARDIAC MONITORING AND TREATMENT DEVICESSeptember 2022July 2024Allow2210NoNo
17909155MEDICAL IMPLANTS AND ELECTRONICS AND ANTENNA ASSEMBLIES FOR USE WITH SAMESeptember 2022September 2025Allow3621NoNo
17900726IMPLANTABLE ELECTRICAL LEADS AND ASSOCIATED DELIVERY SYSTEMSAugust 2022June 2024Allow2120NoNo
17900571IMPLANTABLE ELECTRICAL LEADS AND ASSOCIATED DELIVERY SYSTEMSAugust 2022February 2024Allow1720YesNo
17900558IMPLANTABLE ELECTRICAL LEADS AND ASSOCIATED DELIVERY SYSTEMSAugust 2022February 2024Allow1720YesNo
17891483TELEOPERATED SURGICAL SYSTEM EQUIPMENT WITH USER INTERFACEAugust 2022October 2023Allow1410NoNo
17819796Automated External Defibrillator Systems with Operation Adjustment Features According to Temperature and Methods of UseAugust 2022October 2023Allow1410NoNo
17885528BIOSTIMULATOR HAVING RESILIENT SCAFFOLDAugust 2022October 2023Allow1410YesNo
17816645Lead for the Temporary Stimulation of a Peripheral NerveAugust 2022September 2023Allow1310NoNo
17813377BIOMIMETIC STIMULATOR SYSTEM FOR NEURAL IMPLANTJuly 2022June 2025Allow3511YesNo
17793478AUTOMATED CARDIAC DEFIBRILLATOR PACER WITH INTEGRATED CARDIAC ASSIST DEVICEJuly 2022July 2024Abandon2431YesNo
17864799SLOTTED STIFFENING MEMBER FOR ELECTRODE LEAD INSERTIONJuly 2022January 2024Allow1811NoNo
17857225ELECTROCARDIOGRAM DATA PROCESSING SERVER, METHOD FOR CALCULATING EXPECTED ANALYSIS TIME REQUIRED FOR ELECTROCARDIOGRAM ANALYSIS, AND COMPUTER PROGRAM THEREFORJuly 2022June 2025Allow3511YesNo
17790770IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEVICE WITH HIGH LONGEVITYJuly 2022April 2024Allow2200NoNo
17758283TANDEM BIO-ORGANIC LIGHT-EMITTING DIODE FOR PHOTODYNAMIC THERAPY AND PHOTODYNAMIC APPARATUS COMPRISING SAMEJune 2022June 2025Abandon3511NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BERTRAM, ERIC D.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
1
(33.3%)
Examiner Reversed
2
(66.7%)
Reversal Percentile
88.1%
Higher than average

What This Means

With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
5
Allowed After Appeal Filing
3
(60.0%)
Not Allowed After Appeal Filing
2
(40.0%)
Filing Benefit Percentile
89.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 60.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BERTRAM, ERIC D - Prosecution Strategy Guide

Executive Summary

Examiner BERTRAM, ERIC D works in Art Unit 3796 and has examined 113 patent applications in our dataset. With an allowance rate of 92.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner BERTRAM, ERIC D's allowance rate of 92.0% places them in the 78% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BERTRAM, ERIC D receive 2.55 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BERTRAM, ERIC D is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -6.6% benefit to allowance rate for applications examined by BERTRAM, ERIC D. This interview benefit is in the 4% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.0% of applications are subsequently allowed. This success rate is in the 50% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 46.6% of cases where such amendments are filed. This entry rate is in the 71% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 41% percentile among all examiners. Of these withdrawals, 20.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 43.8% are granted (fully or in part). This grant rate is in the 36% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 11.5% of allowed cases (in the 95% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.